Hanyang Med Rev.  2012 Aug;32(3):127-133. 10.7599/hmr.2012.32.3.127.

Current Status and Future Perspectives of Stem Cells and Regenerative Medicine

• Choi BH
• Park SR

• KMID: 1436760
• DOI: http://doi.org/10.7599/hmr.2012.32.3.127

Abstract

Stem cells and regenerative medicine are emerging and promising fields both in academic and industry points of views. They are currently under active investigation worldwide and their market size is expected to grow rapidly in the near future. The Korean government is also investing a huge amount of money on these fields to promote R&D and product commercialization. However, its technical maturity is still in its infant state and many hurdles should be resolved to accelerate technology to business. I can definitely say that we have to focus in the future on innovations in technology, regulations and reimbursement. In particular, the importance of translational research and clinical studies are of no doubt in the stem cells and regenerative medicine. I am going to deal with some of these issues in more detail in the main text.

Keyword

Stem Cells; Regenerative Medicine; Translational Medical Research; Biomedical Research

MeSH Terms

Commerce
Humans
Infant
Regenerative Medicine
Social Control, Formal
Stem Cells
Translational Medical Research

Figure

• 

  Fig. 1 Various technologies in regenerative medicine.

• 

  Fig. 2 Market estimates of stem cells and regenerative medicine.

Reference

1. Biotech Policy Research Center. Stem cell research and application technologies. 2008. Daejeon: BPRC;Report No. 2008-3.

2. MaRS Advisory Services. Regenerative Medicine. 2009. Toronto: MaRS;Industry Briefing.

3. Biotech Policy Research Center. Trends in Stem Cell Research and Development. 2010. Daejeon: BPRC;BT Technology Report No. 2010-2.

4. Shin YM, Shin HS. Trends in Development of Tissue Engineering Materials Using Biodegradable Polymers. Polymer Science and Technology. 2007. 18:458–464.

5. Kim MS, Kang KS, Lee HB. Trends in Development of Biomaterials for Tissue Engineering. 2006. Osong: Korea Health Industry Development Institute;Health Industry Technology Report 2006-Summer.

6. Korean Agency for Technology and Standards. Industry and Standardization in Tissue Engineering. 2010. Gawcheon, Gyeonggi: KATS;Technology Report No. 16.

7. Jain KK. Cell Therapy, Part I: Technologies & Markets. 2008. Basel, Switzerland: Jain PharmaBiotech;A Jain Pharma Biotech Report.

8. MedMarket Diligence. Tissue Engineering, Cell Therapy and Transplantation: Products, Technologies & Market Opportunities, Worldwide, 2009-2018. 2010. Foothill Ranch, CA, USA: MedMarket Diligence, LLC;Report No. S520.

9. Kalorama Information. Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development. 2008. Rockville, MD, USA: KLI;Pub ID: KLI1597988.

10. Research Impact Technologies. Stem Cell Research. 2008. Andhra Pradesh, India: RI Technologies.

11. Lee HB, et al. Tissue Engineering and Regenerative Medicine2010. 2011. Seoul: Ministry of Health and Welfare;Project Report.